Biogen reaches $900m settlement to resolve kickback allegations
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jul 22
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
20 Jul 22
The expanded collaboration requires SK bioscience to manufacture a version of Novavax’s Covid-19 vaccine that targets the Omicron…
20 Jul 22
The investment will strengthen WuXi Biologics’ global research, development and manufacturing network to meet the growing demand from…
19 Jul 22
Enterome will receive a €40m upfront payment in cash and equity and is eligible to receive additional payments,…
19 Jul 22
Haleon includes a portfolio of global brands including Advil, Centrum, Sensodyne, Robitussin, and TUMS and is expected to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
18 Jul 22
The EC granted conditional marketing authorisation for Kinpeygo based on the efficacy and safety data from Part A…
15 Jul 22
Theravance will receive total consideration of more than $1.5bn, including around $1.1bn in an upfront payment, and up…
14 Jul 22
The US FDA granted the EUA based on data from the Phase 3 PREVENT-19 clinical trial, in which…
13 Jul 22
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
12 Jul 22
Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…